Prolipsi Pharmaceutical Private Limited
About Prolipsi Pharmaceutical Private Limited
Data last updated:
Prolipsi Pharmaceutical Private Limited is a private limited company based in Ranchi, Jharkhand, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 06 June 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Ranchi, under CIN U51397JH2011PTC014899. Its GSTIN is 20AAGCP0808E1Z3 (Jharkhand).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Shyam Kishore Pathak and Kumar Kaushal Kishor.
Its last annual general meeting (AGM) was held on 20 October 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Malti Complex Near Tulsi Apartment Bariatu Road Booty More, Ranchi, Jharkhand, India – 834009.
As per the financials filed for FY 2023, the company reported a revenue of ₹29.43 Lakh, a decline of 24% compared to the previous year. For the same year it recorded a net profit of ₹41,950 (net margin 1.4%) and EBITDA of ₹41,950 (EBITDA margin 1.4%). Revenue has declined at a compounded annual rate (CAGR) of 5% over three years and 6% over five years.
As per MCA filings, the company has open charges of ₹6.5 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressMalti Complex Near Tulsi Apartment Bariatu Road Booty More, Ranchi, Jharkhand, India – 834009
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Prolipsi Pharmaceutical Private Limited
The main business activity of Prolipsi Pharmaceutical is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Prolipsi Pharmaceutical Private Limited FY 2025 filings available
Prolipsi Pharmaceutical Private Limited reported revenue of ₹29.43 Lakh (down 24% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR) of Prolipsi Pharmaceutical Private Limited
Revenue has declined at a compounded annual rate (CAGR) of 6% over five years, including a 24% fall in the latest year. EBITDA fell 58% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Prolipsi Pharmaceutical Private Limited
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹41,950 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹41,950 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Prolipsi Pharmaceutical Private Limited
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.4% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 1.4% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Prolipsi Pharmaceutical are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Prolipsi Pharmaceutical Private Limited
Prolipsi Pharmaceutical Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Klnts Pharmaceuticals Private Limited | ₹29.57 Lakh (FY 2024) | •••• | •••• | 135.0% | •••• | Sriperumbudur, Tamil Nadu, India |
| Farmadel Lifestyle Private Limited | ₹29.55 Lakh (FY 2023) | •••• | •••• | 114.0% | •••• | Ahmedabad, Gujarat, India |
| Laurs & Bridz Pharmaceuticals Private Limited | ₹29.5 Lakh (FY 2024) | •••• | •••• | -1.0% | •••• | Ghaziabad, Uttar Pradesh, India |
| Nectar Pharmaceuticals Pvt. Ltd. | ₹29.48 Lakh (FY 2025) | •••• | •••• | 36.0% | •••• | Kolkata, West Bengal, India |
| Eldinvet Pharmaceuticals Private Limited | ₹29.45 Lakh (FY 2024) | •••• | •••• | -44.0% | •••• | Delhi, India |
| Prolipsi Pharmaceutical Private Limited this company | ₹29.43 Lakh (FY 2023) | •••• | •••• | -24.0% | •••• | Ranchi, Jharkhand, India |
| Kyusep Healthcare Private Limited | ₹29.41 Lakh (FY 2024) | •••• | •••• | 27.0% | •••• | Mumbai, Maharashtra, India |
| Flash Ventures Private Limited | ₹29.39 Lakh (FY 2025) | •••• | •••• | 7.0% | •••• | Mumbai, Maharashtra, India |
| Spectra Lifesciences Private Limited | ₹29.35 Lakh (FY 2017) | •••• | •••• | 21.0% | •••• | Thane, Maharashtra, India |
| Lifeforever Chemist Private Limited | ₹29.24 Lakh (FY 2022) | •••• | •••• | •••• | Mumbai, Maharashtra, India | |
| Litsa Pharmaceuticals Private Limited | ₹29.17 Lakh (FY 2024) | •••• | •••• | -10.0% | •••• | Varanasi, Uttar Pradesh, India |
Peers are the five companies nearest above and the five nearest below Prolipsi Pharmaceutical by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Prolipsi Pharmaceutical Private Limited
Prolipsi Pharmaceutical Private Limited is audited by PRAVEEN S P GUPTA & CO for the financial year 2018.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| PRAVEEN S P GUPTA & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Prolipsi Pharmaceutical Private Limited
Prolipsi Pharmaceutical has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shyam Kishore Pathak | Director | 06 Jun 2011 | 15 Years 4 Months | Current |
| Kumar Kaushal Kishor | Director | 06 Jun 2011 | 15 Years 4 Months | Current |
Ownership and Shareholding of Prolipsi Pharmaceutical Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Prolipsi Pharmaceutical Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 17 Dec 2014 | Idbi Bank Limited | ₹6.5 Lakh | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Prolipsi Pharmaceutical Private Limited
Employment history and EPFO contributions of people linked to Prolipsi Pharmaceutical.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Prolipsi Pharmaceutical Private Limited
Prolipsi Pharmaceutical Private Limited has 3 board changes on record since 2011: 2 appointments and 1 cessation. The latest: Sujeet Kumar ceased to be Director on 04 Oct 2019.
Credit Ratings, Litigation & Regulatory Alerts for Prolipsi Pharmaceutical Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Prolipsi Pharmaceutical Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Prolipsi Pharmaceutical Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Prolipsi Pharmaceutical Private Limited
Prolipsi Pharmaceutical has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 20AAGCP0808E1Z3 | Jharkhand | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Prolipsi Pharmaceutical Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Prolipsi Pharmaceutical Private Limited
Prolipsi Pharmaceutical is an active private limited company based in Ranchi, Jharkhand, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 06 June 2011 (15+ years old) and is registered under CIN U51397JH2011PTC014899.
Prolipsi Pharmaceutical reported revenue of ₹29.43 Lakh for FY 2023 (down 24% YoY).
Prolipsi Pharmaceutical has 2 current directors:
- Shyam Kishore Pathak - Director
- Kumar Kaushal Kishor - Director
Prolipsi Pharmaceutical reported a net profit of ₹41,950 (net margin 1.4%) and EBITDA of ₹41,950 (EBITDA margin 1.4%) for FY 2023, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Prolipsi Pharmaceutical is -5% over three years and -6% over five years. In the latest year (FY 2023) revenue fell 24%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Prolipsi Pharmaceutical is 20AAGCP0808E1Z3, registered in Jharkhand.
The CIN (Corporate Identification Number) of Prolipsi Pharmaceutical is U51397JH2011PTC014899. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Prolipsi Pharmaceutical was incorporated on 06 June 2011, making it 15+ years old. It is registered with the Registrar of Companies, Ranchi.
The peers of Prolipsi Pharmaceutical by revenue are Klnts Pharmaceuticals Private Limited, Farmadel Lifestyle Private Limited, Laurs & Bridz Pharmaceuticals Private Limited, Nectar Pharmaceuticals Pvt. Ltd, Eldinvet Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).
Sujeet Kumar ceased to be Director on 04 Oct 2019. Kumar Kaushal Kishor was appointed as Director on 06 Jun 2011. Shyam Kishore Pathak was appointed as Director on 06 Jun 2011.
The registered office of Prolipsi Pharmaceutical is at Malti Complex Near Tulsi Apartment Bariatu Road Booty More, Ranchi, Jharkhand, India – 834009.